Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: Does Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study

View source ↗

Summary

An ongoing real-world study using propensity score matching to assess whether belimumab alters the natural history of systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Belimumab (belimumab)

Snippet

Sponsor: Biomedical Research Foundation, Academy of Athens | Conditions: SLE - Systemic Lupus Erythematosus | Status: RECRUITING